Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q421336> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Q421336 subject Q10033294.
- Q421336 subject Q18924462.
- Q421336 subject Q7486806.
- Q421336 subject Q9010304.
- Q421336 abstract "Dihydroergotamine (/daɪˌhaɪdroʊ.ɜːrˈɡɒtəmiːn/ dy-HY-droh-ur-GOT-ə-meen; brand names D.H.E. 45 and Migranal) is an ergot alkaloid used to treat migraines. It is a derivative of ergotamine. It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan. Nausea is a common side effect.It has similar actions to the triptans, acting as an agonist to the serotonin 5-HT(1D) receptors and causing vasoconstriction of the intracranial blood vessels, but also interacts centrally with dopamine and adrenergic receptors. It can be used to treat acute intractable headache or withdrawal from analgesics.".
- Q421336 atcPrefix "N02".
- Q421336 atcSuffix "CA01".
- Q421336 bioavailability "32.0".
- Q421336 casNumber "511-12-6".
- Q421336 chEBI "4562".
- Q421336 drugbank "DB00320".
- Q421336 fdaUniiCode "436O5HM03C".
- Q421336 iupacName "(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide".
- Q421336 pubchem "10531".
- Q421336 thumbnail Dihydroergotamine.svg?width=300.
- Q421336 wikiPageExternalLink DHE_45.pdf.
- Q421336 wikiPageExternalLink Migranal.pdf.
- Q421336 wikiPageWikiLink Q10033294.
- Q421336 wikiPageWikiLink Q130146.
- Q421336 wikiPageWikiLink Q133823.
- Q421336 wikiPageWikiLink Q1755275.
- Q421336 wikiPageWikiLink Q1756659.
- Q421336 wikiPageWikiLink Q18924462.
- Q421336 wikiPageWikiLink Q2035485.
- Q421336 wikiPageWikiLink Q416978.
- Q421336 wikiPageWikiLink Q419186.
- Q421336 wikiPageWikiLink Q423866.
- Q421336 wikiPageWikiLink Q432083.
- Q421336 wikiPageWikiLink Q575136.
- Q421336 wikiPageWikiLink Q605709.
- Q421336 wikiPageWikiLink Q620760.
- Q421336 wikiPageWikiLink Q640448.
- Q421336 wikiPageWikiLink Q6445454.
- Q421336 wikiPageWikiLink Q7486806.
- Q421336 wikiPageWikiLink Q7604533.
- Q421336 wikiPageWikiLink Q780128.
- Q421336 wikiPageWikiLink Q9010304.
- Q421336 wikiPageWikiLink Q955948.
- Q421336 atcPrefix "N02".
- Q421336 atcSuffix "CA01".
- Q421336 bioavailability "32".
- Q421336 casNumber "0511-12-06".
- Q421336 chebi "4562".
- Q421336 drugbank "DB00320".
- Q421336 iupacName "-N-[-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1,9,12,14-tetraene-4-carboxamide".
- Q421336 pubchem "10531".
- Q421336 unii "436".
- Q421336 type ChemicalSubstance.
- Q421336 type Drug.
- Q421336 type ChemicalObject.
- Q421336 type Thing.
- Q421336 type Q8386.
- Q421336 comment "Dihydroergotamine (/daɪˌhaɪdroʊ.ɜːrˈɡɒtəmiːn/ dy-HY-droh-ur-GOT-ə-meen; brand names D.H.E. 45 and Migranal) is an ergot alkaloid used to treat migraines. It is a derivative of ergotamine. It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan.".
- Q421336 label "Dihydroergotamine".
- Q421336 depiction Dihydroergotamine.svg.